Ledger.Open graph →
SEC Form D · filed December 26, 2023

Temple Therapeutics Holdings Ltd

Offering
$5.0M
Sold
$25K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GELEEN, P7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Sanj Singh · Saskatoon, Saskatchewan, CanadaExec · DirectorMatthew F. Pruitt · Vancouver, British Columbia, CanadaExec · DirectorKerri L. Dunn · Las Vegas, NVExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗